Senores Pharma Announces 9th AGM on Sep 25, 2026, Releases Annual Report
Senores Pharmaceuticals will hold its 9th AGM on September 25, 2026, via VC/OAVM. The company released its Annual Report for FY 2025-26. E-voting is open from September 22 to September 24, 2026. The cut-off date for eligibility is September 18, 2026.
This is a standard procedural announcement related to an upcoming AGM and the release of the annual report. It does not contain new financial results or strategic changes that would significantly impact the company's stock or operations in the short term.
The announcement is a routine corporate event regarding the AGM and submission of the annual report, with no specific financial or operational performance indicators disclosed in this particular communication.
Senores Pharmaceuticals Limited has announced its Ninth (9th) Annual General Meeting (AGM) will be held on Friday, September 25, 2026, at 11:30 AM IST through Video Conferencing (VC) or Other Audio-Visual Means (OAVM). The company has also submitted its Annual Report, including the Business Responsibility and Sustainability Report, for the Financial Year 2025-26.
Members whose email addresses are registered with the Company or Depository Participants will receive the Annual Report electronically. The cut-off date for determining the list of members eligible for e-voting is Friday, September 18, 2026. Remote e-voting will commence on Tuesday, September 22, 2026, at 09:00 AM IST and conclude on Thursday, September 24, 2026, at 05:00 PM IST.
For members without registered email addresses, a separate communication providing a web link to access the Annual Report on the company's website has been sent. The Annual Report and related documents are also available on the company's website at https://senorespharma.com/reports1/.
What to do with a filing like this
Senores Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Senores Pharmaceuticals Limited. Read the original for the full detail.